Company Profiles

driven by the PitchBook Platform

GeneArrest

2009 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of an anti-gene drug platform. The company develops a computational design of modular polymers that bind a specific sequence of DNA.

Formerly Known As
Antigene Biotechnologies
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
POB 1252, Nazareth Industrial Area "A"
NGT incubator, Sami Shahin building
Nazareth 16000
Israel

+972 (0)4 609 8612
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore GeneArrest’s full profile, request a free trial.

GeneArrest Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding request access »

GeneArrest Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Next Generation Technology Venture Capital Minority 000 0000 000000 0

GeneArrest Executive Team (2)

Name Title Board
Seat
Contact
Info
Mizied Falah Ph.D Co-Founder & Chief Technology Officer
Anwar Rayan Ph.D Co-Founder & Chief Executive Officer